Literature DB >> 17346762

Involvement of UL24 in herpes-simplex-virus-1-induced dispersal of nucleolin.

Maria H Lymberopoulos1, Angela Pearson.   

Abstract

UL24 of herpes simplex virus 1 is important for efficient viral replication, but its function is unknown. We generated a recombinant virus, vHA-UL24, encoding UL24 with an N-terminal hemagglutinin tag. By indirect immunofluorescence at 9 h post-infection (hpi), we detected HA-UL24 in nuclear foci and in cytoplasmic speckles. HA-UL24 partially co-localized with nucleolin, but not with ICP8 or coilin, markers for nucleoli, viral replication compartments, and Cajal bodies respectively. HA-UL24 staining was often juxtaposed to that of another nucleolar protein, fibrillarin. Analysis of HSV-1-induced nucleolar modifications revealed that by 18 hpi, nucleolin staining had dispersed, and fibrillarin staining went from clusters of small spots to a few separate but prominent spots. Fibrillarin redistribution appeared to be independent of UL24. In contrast, cells infected with a UL24-deficient virus retained foci of nucleolin staining. Our results demonstrate involvement of UL24 in dispersal of nucleolin during infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17346762     DOI: 10.1016/j.virol.2007.01.028

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  40 in total

1.  Quantitative proteomics using stable isotope labeling with amino acids in cell culture reveals changes in the cytoplasmic, nuclear, and nucleolar proteomes in Vero cells infected with the coronavirus infectious bronchitis virus.

Authors:  Edward Emmott; Mark A Rodgers; Andrew Macdonald; Sarah McCrory; Paul Ajuh; Julian A Hiscox
Journal:  Mol Cell Proteomics       Date:  2010-05-13       Impact factor: 5.911

Review 2.  Nucleolar targeting: the hub of the matter.

Authors:  Edward Emmott; Julian A Hiscox
Journal:  EMBO Rep       Date:  2009-02-20       Impact factor: 8.807

3.  Human cytomegalovirus UL76 elicits novel aggresome formation via interaction with S5a of the ubiquitin proteasome system.

Authors:  Shin-Rung Lin; Meei Jyh Jiang; Hung-Hsueh Wang; Cheng-Hui Hu; Ming-Shan Hsu; Edward Hsi; Chang-Yih Duh; Shang-Kwei Wang
Journal:  J Virol       Date:  2013-08-21       Impact factor: 5.103

4.  NC-mediated nucleolar localization of retroviral gag proteins.

Authors:  Timothy L Lochmann; Darrin V Bann; Eileen P Ryan; Andrea R Beyer; Annie Mao; Alan Cochrane; Leslie J Parent
Journal:  Virus Res       Date:  2012-10-02       Impact factor: 3.303

5.  Nucleolin associates with the human cytomegalovirus DNA polymerase accessory subunit UL44 and is necessary for efficient viral replication.

Authors:  Blair L Strang; Steeve Boulant; Donald M Coen
Journal:  J Virol       Date:  2009-12-09       Impact factor: 5.103

6.  Nucleolin is required for efficient nuclear egress of herpes simplex virus type 1 nucleocapsids.

Authors:  Ken Sagou; Masashi Uema; Yasushi Kawaguchi
Journal:  J Virol       Date:  2009-12-02       Impact factor: 5.103

7.  Nucleolar localization of influenza A NS1: striking differences between mammalian and avian cells.

Authors:  Romain Volmer; Beryl Mazel-Sanchez; Christelle Volmer; Sébastien M Soubies; Jean-Luc Guérin
Journal:  Virol J       Date:  2010-03-17       Impact factor: 4.099

8.  The major tegument structural protein VP22 targets areas of dispersed nucleolin and marginalized chromatin during productive herpes simplex virus 1 infection.

Authors:  María R López; Elisabeth F M Schlegel; Sandra Wintersteller; John A Blaho
Journal:  Virus Res       Date:  2008-06-12       Impact factor: 3.303

9.  Virus-Induced Chaperone-Enriched (VICE) domains function as nuclear protein quality control centers during HSV-1 infection.

Authors:  Christine M Livingston; Marius F Ifrim; Ann E Cowan; Sandra K Weller
Journal:  PLoS Pathog       Date:  2009-10-09       Impact factor: 6.823

10.  Upstream-binding factor is sequestered into herpes simplex virus type 1 replication compartments.

Authors:  Nigel D Stow; Vanessa C Evans; David A Matthews
Journal:  J Gen Virol       Date:  2009-01       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.